CD13: A Key Player in Multidrug Resistance in Cancer Chemotherapy
2020 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 33 citations
https://doi.org/10.3727/096504020x15919605976853
Q
Qie Guo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
733
Citations
16
h-index
24
i10-index
Qie Guo is an academic researcher from Qingdao University. The author has contributed to research in topics: Cancer Mechanisms and Therapy & Immunotherapy and Immune Responses & Macrophage Migration Inhibitory Factor. The author has an h-index of 16, co-authored 52 publications.
ORCID: 0000-0002-6572-3205Papers by this author
worksNano-formulations in disease therapy: designs, advances, challenges, and future directions
2025 · Journal of Nanobiotechnology · 21 citations
https://doi.org/10.1186/s12951-025-03442-7
Ubenimex Reverses MDR in Gastric Cancer Cells by Activating Caspase-3-Mediated Apoptosis and Suppressing the Expression of Membrane Transport Proteins
2019 · BioMed Research International · 20 citations
https://doi.org/10.1155/2019/4390839
Combating drug resistance in hepatocellular carcinoma: No awareness today, no action tomorrow
2023 · Biomedicine & Pharmacotherapy · 16 citations
https://doi.org/10.1016/j.biopha.2023.115561
Risk of pulmonary fungal infections associated with biologics: a FAERS database disproportionality analysis
2025 · Frontiers in Immunology · 3 citations
https://doi.org/10.3389/fimmu.2025.1672343
Deciphering the role of non-coding RNAs involved in sorafenib resistance
2024 · Heliyon · 2 citations
https://doi.org/10.1016/j.heliyon.2024.e29374
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat